Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01937195 · ClinicalTrials.gov registry record · NA

AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)

A NA study, sponsored by C. R. Bard.

Completed
Registry status
NA
Development phase
95
Enrollment target

NCT01937195: Completed NA study, sponsored by C. R. Bard.

NCT01937195 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01937195, a NA study, has completed, sponsored by C. R. Bard.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target

Study Summary

The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (PIV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to Conventional IV Catheters.

Primary Outcome

The primary endpoint is to observe the rate of first attempt success (where the inserter only pierces the skin once and successfully places the PIV catheter in the vein) in patients requiring PIV access.

Interventions

  • DEVICE AccuCath Intravenous Catheter System

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2013-04
Est. Completion 2014-11
Phase NA
C. R. Bard

75 total trials

What the finished NCT01937195 record still lists

NCT01937195 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which AccuCath Intravenous Catheter System is the first listed.

NCT01937195 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01937195 about?

NCT01937195 is a clinical study titled "AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)". The study will test a hypothesis that the AccuCath™ System will have a higher rate of successful first attempt peripheral intravenous (PIV) placement, higher completion of therapy, fewer complications, longer dwell times, and higher user satisfaction compared to Conventional IV Catheters.

What is the current status of trial NCT01937195?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2013-04. Estimated completion is 2014-11.

What interventions are being tested in trial NCT01937195?

The interventions under investigation include: AccuCath Intravenous Catheter System (DEVICE).

Who is sponsoring clinical trial NCT01937195?

This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01937195's enrollment target sits among peer trials

95 931st of 2000 higher than 1,066 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01937195, the US trial registry maintained by the National Library of Medicine. NCT01937195 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.